Palisade Bio (PALI) Receivables (2011 - 2026)

Palisade Bio (PALI) posted quarterly Receivables of $250000.0 for Q1 2023, up 76.99% quarter-over-quarter from $141250.0 in Q4 2022.

Palisade Bio (PALI) Receivables (2011 - 2026) Analysis & Trends

Palisade Bio (PALI) has reported Receivables for 13 consecutive years, with $250000.0 the latest figure, recorded in Q1 2023.

  • In Q1 2023, Receivables changed N/A year-over-year to $250000.0; the TTM figure through Mar 2023 stood at $250000.0 (changed N/A YoY), while the FY2022 annual figure was $141250.0, changed N/A from the prior year.
  • Receivables rose to $250000.0 in Q1 2023 per PALI's latest filing, from $141250.0 in the prior quarter.
  • Across five years, Receivables topped out at $466782.0 in Q1 2019 and bottomed at $21064.0 in Q4 2019.
  • Historically, Receivables has averaged $222678.8 across 5 years, with a median of $246976.0 in 2020.
  • Annual changes were most pronounced in 2019 — Receivables sank 94.12% — and 2020, when it soared 1267.26%.
  • Palisade Bio's Receivables stood at $21064.0 in 2019, then jumped by 1267.26% to $288000.0 in 2020, then sank by 79.51% to $59000.0 in 2021, then surged by 139.41% to $141250.0 in 2022, then soared by 76.99% to $250000.0 in 2023.
  • Business Quant data shows PALI's Receivables at $250000.0 in Q1 2023, $141250.0 in Q4 2022, and $59000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.93 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.06 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 1.84 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 912.74 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 215.33 Mn
10 Palisade Bio 372.94 Mn 247.74 Mn - 500,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 500,000.00
Mar 31, 2023 250,000.00
Dec 31, 2022 141,250.00
Jun 30, 2021 59,000.00
Mar 31, 2021 25,259.00
Dec 31, 2020 288,000.00
Sep 30, 2020 237,779.00
Jun 30, 2020 245,938.00
Mar 31, 2020 248,014.00
Dec 31, 2019 21,064.00
Sep 30, 2019 290,154.00
Jun 30, 2019 398,905.00
Mar 31, 2019 466,782.00
Dec 31, 2018 357,995.00
Sep 30, 2018 224,227.00
Jun 30, 2018 478,722.00
Mar 31, 2018 137,372.00
Dec 31, 2017 371,586.00
Sep 30, 2017 595,458.00
Jun 30, 2017 563,345.00